QIAGEN expands business in Middle East with new regional headquarters and major projects
Venlo, the Netherlands, Muscat, Oman, and Riyadh, Saudi Arabia, Jan. 03, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime […]
Spruce Ridge Enters into Settlement with Former CEO
TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Spruce Ridge Resources Ltd. (“Spruce Ridge” or the “Company”) (TSX-V: SHL) announces that […]
OROCO ANNOUNCES PRIVATE PLACEMENT
Vancouver, Canada, Jan. 02, 2024 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or “the Company”) is […]
ARCPOINT ANNOUNCES US$1.6 MILLION NON-BROKERED PRIVATE PLACEMENT
For Immediate Release – Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, Jan. […]
AutoZone Announces Completion of Leadership Transition Plan
MEMPHIS, Tenn., Jan. 02, 2024 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) completed its Leadership Transition Plan announced on June […]
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology […]
Sparton Announces Closing of Second Tranche of Private Placement Offering For its Critical Metals Exploration Programs
Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, Jan. 02, 2024 (GLOBE […]
Euro Manganese Announces Resignation of Board Member
VANCOUVER, British Columbia, Jan. 02, 2024 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) […]
Eldorado Gold Announces Appointment of Paul Ferneyhough as Executive Vice President and Chief Financial Officer
VANCOUVER, British Columbia, Jan. 02, 2024 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or the “Company”) today announces the appointment […]
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical […]
